Wagenbauer, Klaus F.
Pham, Nhi
Gottschlich, Adrian http://orcid.org/0000-0002-2898-4182
Kick, Benjamin
Kozina, Viktorija
Frank, Christopher
Trninic, Daniela
Stömmer, Pierre http://orcid.org/0000-0003-1683-3392
Grünmeier, Ruth http://orcid.org/0000-0002-9044-3600
Carlini, Emanuele
Tsiverioti, Christina Angeliki
Kobold, Sebastian http://orcid.org/0000-0002-5612-4673
Funke, Jonas J.
Dietz, Hendrik http://orcid.org/0000-0003-1270-3662
Article History
Received: 30 January 2023
Accepted: 26 June 2023
First Online: 17 August 2023
Competing interests
: The Technical University of Munich has filed several patents listing K.F.W., J.J.F., B.K. and H.D. as the inventors. K.F.W., J.J.F., B.K. and H.D. are co-founders of Plectonic Biotech GmbH. S.K. has received honoraria from TCR2 Inc., Novartis, Miltenyi Biomedicines, BMS and GSK. S.K. and A.G. are inventors of several patents in the field of immuno-oncology (approved, S.K., PCT/EP2013/051351, PCT/EP2016/064195, PCT/EP2016/074644; pending, S.K., PCT/EP2020/056086; submitted, S.K. and A.G., EP21191376, EP 23 154 047.78; countries, Europe, USA, Canada). S.K. received license fees from TCR2 Inc. and Carina Biotech. S.K. received research support from Plectonic GmbH for parts of the work contained herein. S.K. received research support from TCR2 Inc. and Arcus Bioscience for work unrelated to the manuscript. A.G. received research support from Tabby Therapeutics for work unrelated to the manuscript. The remaining authors declare no competing interests.